Stay updated on ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial
Sign up to get notified when there's something new on the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page.

Latest updates to the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page header.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 on the study page, representing an administrative update with no changes to study data or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedUI updates include the glossary toggle and capitalization changes to QC-related labels. The revision tag has been updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page header, a minor maintenance change with no impact on content or functionality.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a Locations section with France as a study site and updated the page revision to v3.3.3; the old France Locations entry was removed.SummaryDifference0.2%

Stay in the know with updates to ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page.